Publications by authors named "Michael Kurowski"

Claim this Profile
L
Lopinavir/ritonavir pharmacokinetics, efficacy, and safety in HIV and hepatitis B or C coinfected adults without symptoms of hepatic impairment.
Pavel Khaykin, Peter Kotzerke, Christoph Stephan, Gabi Nisius, Markus Bickel, Michael Kurowski

Ther Drug Monit· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of etravirine 400 mg once daily in treatment-naïve patients.
Giovanni Di Perri, Bruce Green, Glynn Morrish, Andrew Hill, Gerd Faetkenheuer, Michael Kurowski

HIV Clin Trials· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oseltamivir distributes to influenza virus replication sites in the middle ear and sinuses.
Michael Kurowski, Charles Oo, Hugh Wiltshire, Joanne Barrett

Clin Drug Investig· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daily dosing of tacrolimus in patients treated with HIV-1 therapy containing a ritonavir-boosted protease inhibitor or raltegravir.
Markus Bickel, Evrim Anadol, Martin Vogel, Wolf Peter Hofmann, Nils von Hentig, Michael Kurowski

J Antimicrob Chemother· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atazanavir plasma concentrations are impaired in HIV-1-infected adults simultaneously taking a methadone oral solution in a once-daily observed therapy setting.
Annette Haberl, Manfred Moesch, Gabriele Nisius, Christoph Stephan, Markus Bickel, Michael Kurowski

Eur J Clin Pharmacol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety and efficacy of saquinavir/ ritonavir 1,000/100 mg twice daily as HIV type-1 therapy and transmission prophylaxis in pregnancy.
Nils von Hentig, Gabi Nisius, Tessa Lennemann, Pavel Khaykin, Christoph Stephan, Michael Kurowski

Antivir Ther· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of nevirapine in breast milk and plasma of mothers and their children after single-dose administration.
Andrea Kunz, Monika Frank, Kizito Mugenyi, Rose Kabasinguzi, Astrid Weidenhammer, Michael Kurowski

J Antimicrob Chemother· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fosamprenavir/ritonavir plus tenofovir does not affect amprenavir pharmacokinetics: no effect of tenofovir.
Michael Kurowski, Ravi K Walli, Antje Breske, Guido Kruse, Hartmut Stocker

AIDS· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrapartum transmission after mucosal exposure to HIV was not observed with single-dose nevirapine for mother and child.
Andrea Kunz, Kizito Mugenyi, Heiko Karcher, Angelika Mayer, Shirin Simo, Michael Kurowski

J Acquir Immune Defic Syndr· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of saquinavir, atazanavir, and ritonavir in a twice-daily boosted double-protease inhibitor regimen.
Nils von Hentig, Axel Müller, Carsten Rottmann, Timo Wolf, Thomas Lutz, Michael Kurowski

Antimicrob Agents Chemother· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saquinavir, nelfinavir and M8 pharmacokinetics following combined saquinavir, ritonavir and nelfinavir administration.
Hartmut Stocker, Christian Herzmann, Antje Breske, Guido Kruse, Marcel Berger, Michael Kurowski

J Antimicrob Chemother· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of the steady-state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy.
Nils von Hentig, Amina Carlebach, Peter Gute, Gaby Knecht, Stefan Klauke, Michael Kurowski

Br J Clin Pharmacol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery.
Andrea Gingelmaier, Michael Kurowski, Ralph Kästner, Josef Eberle, Ioannis Mylonas

AIDS· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of enfuvirtide in patients treated in typical routine clinical settings.
Hartmut Stocker, Charlotte Kloft, Nele Plock, Antje Breske, Guido Kruse, Michael Kurowski

Antimicrob Agents Chemother· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nevirapine concentration in cervicovaginal and oropharyngeal secretions after single-dose administration to the mother.
Gundel Harms, Andrea Kunz, Heiko Karcher, Kizito Mugenyi, Michael Kurowski

Antivir Ther· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe CNS side-effect and persistent high efavirenz plasma levels in a patient with HIV/HCV coinfection and liver cirrhosis.
Markus Bickel, Christoph Stephan, Carsten Rottmann, Amina Carlebach, Anette Haberl, Michael Kurowski

Scand J Infect Dis· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs.
Marta Boffito, Edward Acosta, David Burger, Courtney V Fletcher, Charles Flexner, Michael Kurowski

Antivir Ther· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The steady-state pharmacokinetics of nelfinavir in combination with tenofovir in HIV-infected patients.
Guido Kruse, Stefan Esser, Hartmut Stocker, Antje Breske, Andreas Koerber, Michael Kurowski

Antivir Ther· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status and future prospects of therapeutic drug monitoring and applied clinical pharmacology in antiretroviral therapy.
Marta Boffito, Edward Acosta, David Burger, Courtney V Fletcher, Charles Flexner, Michael Kurowski

Antivir Ther· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis.
Ildiko R Dunay, Markus M Heimesaat, Faris Nadiem Bushrab, Rainer H Müller, Hartmut Stocker, Michael Kurowski

Antimicrob Agents Chemother· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nevirapine significantly reduces the levels of racemic methadone and (R)-methadone in human immunodeficiency virus-infected patients.
Hartmut Stocker, Guido Kruse, Peter Kreckel, Christian Herzmann, Keikawus Arastéh, Michael Kurowski

Antimicrob Agents Chemother· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.
Mathias W R Pletz, Mareike Rau, Juergen Bulitta, Andres De Roux, Olaf Burkhardt, Michael Kurowski

Antimicrob Agents Chemother· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atazanavir enhances saquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen.
Marta Boffito, Michael Kurowski, Guido Kruse, Andrew Hill, Andrew A Benzie

AIDS· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Saquinavir drug exposure is not impaired by the boosted double protease inhibitor combination of lopinavir/ritonavir.
Christoph Stephan, Nils von Hentig, Irene Kourbeti, Brenda Dauer, Manfred Mösch, Michael Kurowski

AIDS· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited effect of food composition on the pharmacokinetics of nelfinavir administered twice daily.
Michael Kurowski, B Kaeser, A Sawyer, M Popescu, A Mroziekiewicz

Eur J Med Res· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis